Is Your Gut Microbiome Lowering Your Testosterone?

Your gut bacteria don't just digest food — emerging evidence suggests specific microbial strains actively degrade testosterone before it reaches systemic circulation, a mechanism researchers now call the "testobolome." For men already borderline hypogonadal, this microbial interference may tip the scale toward clinical deficiency.

How Gut Bacteria Metabolize — and Destroy — Testosterone

Certain intestinal bacteria express 3β/17β-hydroxysteroid dehydrogenase (3/17β-HSD), an enzyme that converts testosterone into less active metabolites. In one study examining men with hyperlipidemia, fecal microbiota completely degraded testosterone within 96 hours in a culture model — while 40% of healthy controls showed zero degradation activity [6]. A 2024 systematic review and meta-analysis [1] found that men with low testosterone consistently harbor higher abundances of Blautia, Lachnoclostridium, and Lachnospirales — taxa negatively correlated with serum testosterone even after adjusting for BMI, insulin resistance, and CRP — and proposed the term testobolome to describe this microbial network [3].

The pathway runs both directions. Gut bacterial β-glucuronidases deconjugate testosterone glucuronide in the intestinal lumen, potentially reactivating it for reabsorption. Whether a given man's microbiome tips toward reactivation or degradation depends on which organisms dominate [14, 3].

What the Human Data Actually Show

A 2019 study by Shin et al. found men in the high-testosterone group showed greater gut microbial alpha diversity and higher abundance of Ruminococcus and Acinetobacter [9]. In a study of 46 men with type 2 diabetes, the testosterone-deficient group showed markedly higher Blautia and Lachnospirales — both correlated with CRP and HOMA-IR — while Christensenellaceae R-7 was depleted [2].

Diagnosis still rests on two early-morning total testosterone measurements below ~300 ng/dL plus consistent symptoms. When evaluating your options, comparing specialized TRT providers who run comprehensive metabolic panels alongside standard testosterone labs is worth considering. You can also review how functional hypogonadism is treated before your first appointment.

Implications for Men on TRT

For men on oral testosterone formulations like Jatenzo, the gut environment directly shapes pharmacokinetics — bacterial β-glucuronidase activity determines how much conjugated testosterone gets reactivated versus degraded [3, 6]. Two men taking identical doses could have meaningfully different serum exposures based on microbiome composition alone.

For injectable protocols, chronic dysbiosis promotes endotoxemia and elevated CRP, blunting GnRH secretion and reducing LH output — particularly relevant for men considering Clomid or Androxal, since a pro-inflammatory gut may limit how well those signals translate to testicular output. A 2025 NHANES-based analysis found that high dietary live-microbe intake was associated with significantly lower testosterone deficiency risk [5], suggesting diet-driven microbiome optimization is a legitimate adjunct to hormone therapy.

Marek Health runs comprehensive labs — including inflammatory markers and metabolic panels — that can surface the dysbiosis-hypogonadism overlap most standard panels miss.

---

FAQ

Q: Can fixing my gut microbiome raise my testosterone? A: Human intervention data are limited, but studies show probiotic supplementation and fermented food intake correlate with modestly higher testosterone in some populations. It's unlikely to replace TRT in clinically deficient men but may improve response.

Q: Which gut bacteria are most harmful to testosterone? A: Current evidence points to Blautia, Lachnoclostridium, and organisms expressing 3/17β-HSD — including Paracoccus nitroreducens — as the primary degraders [1, 6].

Q: Does this affect men on TRT differently than untreated men? A: Yes. For oral testosterone especially, microbiome composition influences absorption and first-pass metabolism. Even on injectables, dysbiosis-driven inflammation can suppress residual HPG axis function [3].

Frequently asked questions

What is the testobolome and how does it affect testosterone levels?

The testobolome is the microbial network within the gut that processes androgens, including testosterone, and can actively lower circulating levels before they reach systemic circulation. A 2024 systematic review and meta-analysis coined the term by drawing a direct parallel to the estrobolome concept in women's health research, and found that men with low testosterone consistently harbor higher abundances of Blautia, Lachnoclostridium, and Lachnospirales — taxa negatively correlated with serum testosterone even after adjusting for BMI, insulin resistance, and CRP. In culture models, fecal microbiota from men with hyperlipidemia completely degraded testosterone within 96 hours, while 40% of healthy controls showed zero degradation activity.

Can gut bacteria affect how well oral testosterone medications like Jatenzo work?

Gut microbiome composition can directly alter the pharmacokinetics of oral testosterone formulations like Jatenzo (testosterone undecanoate), meaning two men taking identical doses could have meaningfully different serum exposures. Bacterial β-glucuronidases determine how much conjugated testosterone gets reactivated in the intestinal lumen, while 3/17β-HSD-expressing organisms like Paracoccus nitroreducens can simultaneously degrade it — and whichever process dominates depends on which microbial strains are most abundant in that individual's gut.

Does eating fermented foods actually help with low testosterone caused by gut dysbiosis?

A 2025 NHANES-based analysis found that high dietary live-microbe intake — including fermented foods, yogurt, and aged cheese — was associated with significantly lower testosterone deficiency risk, suggesting diet-driven microbiome optimization may be a legitimate adjunct to hormone therapy. Chronic gut dysbiosis promotes endotoxemia and elevated CRP, both of which blunt GnRH secretion and reduce LH output, so reducing that inflammatory burden through diet may support the HPG axis — a consideration especially relevant for men using SERMs like Clomid (clomiphene) or Androxal (enclomiphene) that depend on intact LH signaling to stimulate testicular testosterone production.